TCL Archive DCT Board Approves Contract Recompetitions Worth 44.8 Million In First Year Awards November 5, 1982
TCL Archive Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival November 29, 2013
TCL Archive New Therapeutic Modalities In Testing For Patients With Carcinoid Syndrome November 28, 2003